Lifeboat Foundation

Continue reading “Bioquark — Electroceuticals — Real Bodies” »

Analyst Salveen Richter and colleagues laid it out:

The potential to deliver “one shot cures” is one of the most attractive aspects of gene therapy, genetically engineered cell therapy, and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies… While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.

For a real-world example, they pointed to Gilead Sciences, which markets treatments for hepatitis C that have cure rates exceeding 90 percent. In 2015, the company’s hepatitis C treatment sales peaked at $12.5 billion. But as more people were cured and there were fewer infected individuals to spread the disease, sales began to languish. Goldman Sachs analysts estimate that the treatments will bring in less than $4 billion this year.

Continue reading “‘Is curing patients a sustainable business model?’ Goldman Sachs analysts ask” »

By 2020, China plans to assign each of its 1.4 billion citizens a “social credit score” that will determine what people are allowed to do, and where they rank in society.

It’s part of a broad effort in China to build a so-called reputation system that will measure, in theory, the credibility of government officials and businesses, in addition to citizens. The Chinese government says the system will boost “trust” nationwide and build a culture of “sincerity.”

Continue reading “How China’s ‘social credit score’ will punish and reward citizens” »

Space, Oceans, Literature, Entertainment, Sports, Medicine, Fashion, Longevity — Honored to be among this group of thinkers, coming up with the innovative ideas that shape the future — http://radioideaxme.com

February 4th, 2019 sees the launch of the Longevity Leaders Conference in St Paul’s, London, which promises to be an interesting event on the conference calendar.

The conference aims to cover both the science of aging research and the business side of the industry, in a similar manner to our own annual conference, Ending Age-Related Diseases, which we host in New York. Mixing the worlds of science and business is a good idea as we move ever closer to the first true rejuvenation technologies arriving.

It is essential to begin forging bonds between the researchers who are making the science a reality and the investors and angels who have the knowledge and expertise to take the science to market.

by Russell Corlett, health and safety director for Peninsula. The HR and employment law business consultant is based in Manchester and has over 30 years’ experience, as well as an international presence in Australia, Canada, and New Zealand.

Health and safety has faced a major upheaval in recent years. The arrival of the digital revolution, and changing corporate and social attitudes, has seen a seismic shift in how the industry operates.

As we adapt to technological advancements and diverse workplaces, let’s break out a crystal ball, examine the available evidence, and see where things may be a decade from now. The future of business While we can’t say for sure what will happen, it’s possible to make an educated guess. There are already white papers speculating on the future business world, such as a detailed analysis by professional services network PwC. This report suggests four potential outcomes by 2030:

WASHINGTON — The Defense Advanced Research Projects Agency has awarded satellite operator Telesat a contract to study the use of commercial buses in the agency’s experimental low-Earth-orbit constellation program known as Blackjack.

Telesat of Ottawa, Canada, is the third company to receive a study contract for Blackjack, a DARPA demonstration mission that envisions deploying 20 satellites — each carrying one or more payloads. DARPA’s goal is to find lower cost alternatives to traditional military satellites. DARPA aims to pay no more than $6 million per satellite, including launch. European satellite manufacturer Airbus Defence and Space and small satellite manufacturer Blue Canyon Technologies of Boulder, Colorado, received similar contracts over the past four weeks.

Telesat’s contract, which the company announced Nov. 27, is a 12-month study to assess the utility of Telesat buses as the company refines its plans for a constellation of roughly 300 small, broadband satellites. Telesat has yet to select a manufacturer for its satellites. Two contenders, Airbus Defence and Space and a team formed by Thales Alenia Space and Maxar Technologies, are competing to build an unspecified number of satellites. Michael Schwartz, Telesat’s senior vice president of corporate and business development said the company still plans to down select a manufacturer in the spring.

Continue reading “Telesat wins study contract for DARPA’s experimental constellation” »

Ground control to major Jeff (Bezos).

Amazon Web Services (AWS), the company’s cloud computing arm, just announced a new offering aimed at satellite operators.

The news: At its annual re: Invent conference in Seattle this week, the web giant unveiled a service that lets owners of satellites rent time on Amazon-managed ground stations to send and receive data from orbit. The service, called AWS Ground Station, works in much the same way as Amazon’s well-established business for tapping computing capacity via the cloud.

Continue reading “Amazon is launching pay-as-you-go cloud computing in space” »